Skip to main navigation Skip to search Skip to main content

I-Corps: Flow regulated nasal oxygen delivery device

Project: Research

Abstract & Details

Description

Award ID: 2328698

The broader impact/commercial potential of this I-Corps project is the development of a medical device for monitoring the ventilation of patients receiving oxygen therapy by nasal cannula, and for autonomously adjusting ventilator settings based on the measurements of the monitor. Currently, nasal cannula patients in many hospitals are checked infrequently due to their relative non-severity compared to patients treated with positive pressure ventilation, and current cannula devices have no way to monitor patient ventilation. Taken together, this leads to delayed care due to staffing shortages and worsening outcomes due to the lack of an early warning system or any quantifiable patient data. A device that is designed to monitor the oxygen demands of cannula patients and autonomously react to increases/decreases in patient oxygen demands may improve outcomes in hospitals and enable hospitals to improve patient outcomes in the face of respiratory therapist staffing shortages. This I-Corps project is based on the development of a method for noninvasively estimating the flowrate of air through a patients nasal passage based on pressure measurements taken inside the nose during respiration. Using a specially designed cannula capable of taking these measurements during operation, the method may be used to estimate the volumes of air inspired by the patient during oxygen therapy. Successful estimation of these volumes requires careful data processing and detailed information about the relationship between air pressure and flow in the human nasal passage. A prototype device was shown to measure the inspired volumes of air in a mannequin with precision in the order of milliliters and accuracy in the order of 5%. These results indicate that the proposed technology may be implemented into a commercial medical device capable of monitoring and reacting to changes in the respiratory status of patients receiving oxygen therapy via nasal cannula. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Ruth Shuman
StatusClosed
Effective start/end date09/01/2302/28/25

Funding

  • I-Corps Teams: $50,000.00

Active Fiscal Year

  • FY2024
  • FY2023
  • FY2025

Start Fiscal Year

  • FY2023

TIP Programs

  • I-Corps Teams

Key Technology Areas

  • Biotechnology
  • (confidence score: 96%)

Technology Foci

  • Medical Technology
  • (confidence score: 98%)

Congressional District at Award

  • District n. 09 of Virginia

Current Congressional District

  • District n. 09 of Virginia

United States

  • Virginia

Core Based Statistical Area (CBSA)

  • Blacksburg-Christiansburg-Radford, VA

County

  • County: Montgomery, VA

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine